IGC Pharma, Inc. (IGC)
(Delayed Data from AMEX)
$0.40 USD
-0.02 (-4.50%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $0.39 -0.01 (-2.28%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IGC 0.40 -0.02(-4.50%)
Will IGC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for IGC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IGC
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates
IGC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates
IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates
Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates
Other News for IGC
MACD Bullish Signal Line Cross appears for IGC after 1.44% move
IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders
20 Day Moving Average Support appears for IGC after 2.69% move
Is IGC primed for upward momentum? Crossed Above 20 Day Moving Average shows up after rising 1.95%
IGC's Latest Discovery in Alzheimer's Treatment Shows Promise